Original Research
Published on 30 Oct 2023
PDGF, NGF, and EGF as main contributors to tumorigenesis in high-risk retinoblastoma
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1144951
- 1,909 views
- 3 citations
- Frontiers in Oncology
- Pediatric Oncology
- Articles
Type at least 3 characters
560 articles
Perspective
Published on 30 Oct 2023
Pediatric precision oncology: “better three hours too soon than a minute too late”
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1279953
- 1,555 views
- 1 citation
Original Research
Published on 27 Oct 2023
Invasive fungal infections in pediatric patients with central nervous system tumors: novel insights for prophylactic treatments?
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1248082
- 1,727 views
- 1 citation
Systematic Review
Published on 27 Oct 2023
A systematic review of data sources for artificial intelligence applications in pediatric brain tumors in Europe: implications for bias and generalizability
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1285775
- 2,550 views
- 2 citations
Original Research
Published on 26 Oct 2023
Factors influencing delayed clearance of high dose methotrexate (HDMTX) in pediatric, adolescent, and young adult oncology patients
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1280587
- 3,450 views
- 8 citations
Retraction
Published on 26 Oct 2023
Retraction: Identification of hub genes and construction of prognostic nomogram for patients with Wilms tumors
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1301668
- 1,488 views
Original Research
Published on 13 Oct 2023
Prognostic value of systemic inflammation response index in hepatoblastoma patients receiving preoperative neoadjuvant chemotherapy
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1276175
- 1,979 views
- 7 citations
Original Research
Published on 10 Oct 2023
VRK3 depletion induces cell cycle arrest and metabolic reprogramming of pontine diffuse midline glioma - H3K27 altered cells
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1229312
- 2,895 views
Review
Published on 10 Oct 2023
Novel therapeutic approaches for pediatric diencephalic tumors: improving functional outcomes
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1178553
- 2,968 views
Original Research
Published on 10 Oct 2023
CritCom: assessment of quality of interdisciplinary communication around deterioration in pediatric oncologic patients
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1207578
- 2,504 views
Original Research
Published on 04 Oct 2023
Unraveling the impact of upfront chemotherapy and proton beam therapy on treatment outcome and follow-up in central nervous system germ cell tumors: a single center experience
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1259403
- 2,077 views
- 1 citation
Original Research
Published on 02 Oct 2023
Primary presentation and clinical course of pediatric and adolescent patients with differentiated thyroid carcinoma after radioiodine therapy
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1237472
- 1,211 views
- 1 citation
Mini Review
Published on 26 Sep 2023
Hyperbaric oxygen therapy as a complementary treatment in neuroblastoma — a narrative review
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1254322
- 8,501 views
- 5 citations
Original Research
Published on 21 Sep 2023
Prognostic factors and predictive scores for 6-months mortality of hematopoietic stem cell transplantation recipients admitted to the pediatric intensive care unit
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1161573
- 2,226 views
- 3 citations
Original Research
Published on 19 Sep 2023
Ferroptosis regulator NOS2 is closely associated with the prognosis and cell malignant behaviors of hepatoblastoma: a bioinformatic and in vitro study
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1228199
- 4,178 views
- 2 citations
Review
Published on 13 Sep 2023
Bridging the age gap: a review of molecularly informed treatments for glioma in adolescents and young adults
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1254645
- 4,617 views
- 4 citations